Gene therapy product quality aspects in the production of vectors and genetically modified somatic cells

  • Email
  • Help
Current effective version

Adopted guideline

Reference number3AB6A
Effective from01/07/1995
KeywordsRecominant, DNA, rDNA, somatic cells, vectors
DescriptionThis document provides quality recommendation for gene therapy products derived by biotechnology/high technology and intended for human use. It aims to facilitate the collection and submission of data to support applications for marketing authorisation.

Related content

How helpful is this page?

Average rating:

 Based on 20 ratings

Add your rating:

See all ratings
4 ratings
4 ratings
4 ratings
4 ratings
4 ratings

Tell us more